Autolus Therapeutics Long Term Deferred Assets (Quarterly) Analysis

Autolus Therapeutics Plc (AUTL)

1.67 +0.03 (+1.83%) USD | NASDAQ | Feb 20, 16:00

1.675 0.00 (0.00%) After-Hours: 20:00

View Long Term Deferred Assets (Quarterly) for AUTL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Biodexa Pharmaceuticals Plc	--
NuCana Plc	Upgrade
Mereo BioPharma Group Plc	--
Bicycle Therapeutics Plc	--
DBV Technologies SA	--